3828 Federal Register / Vol. 87, No. 16 / Tuesday, January 25, 2022 / Notices 

3. Questions on systems matters may 

be directed to: 

Paul Gettys, Acting Director, Indian 

Health Service, Division of Grants 

Management, 5600 Fishers Lane, Mail 

Stop: 09E70, Rockville, MD 20857, 

Phone: (301) 443–2114; or the DGM 

main line (301) 443–5204, Email: 

Paul.Gettys@ihs.gov. 

VIII. Other Information 

The Public Health Service strongly 

encourages all grant, cooperative 

agreement, and contract recipients to 

provide a smoke-free workplace and 

promote the non-use of all tobacco 

products. In addition, Public Law 103– 

227, the Pro-Children Act of 1994, 

prohibits smoking in certain facilities 

(or in some cases, any portion of the 

facility) in which regular or routine 

education, library, day care, health care, 

or early childhood development 

services are provided to children. This 

is consistent with the HHS mission to 

protect and advance the physical and 

mental health of the American people. 

Elizabeth A. Fowler, 

Acting Deputy Director, Indian Health 

Service. 

[FR Doc. 2022–01322 Filed 1–24–22; 8:45 am] 

BILLING CODE 4165–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Cardiovascular Disease Risk and Diet 

Induced Circadian Dysfunction. 

Date: March 3, 2022. 

Time: 9:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6705 

Rockledge Drive, Bethesda, MD 20817 

(Virtual Meeting). 

Contact Person: Shelley S. Sehnert, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Room 208–T, 

Bethesda, MD 20892–7924, (301) 827–7984, 

ssehnert@nhlbi.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Career Development Program to Promote 

Diversity in Health Research. 

Date: March 4, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6705 

Rockledge Drive, Bethesda, MD 20817 

(Virtual Meeting). 

Contact Person: Sun Saret, Ph.D., Scientific 

Review Officer, Office of Scientific Review/ 

DERA, National Heart, Lung, and Blood 

Institute, National Institutes of Health, 6705 

Rockledge Drive, Room 208–S, Bethesda, MD 

20892, (301) 435–0270, sun.saret@nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Early Phase Clinical Trials (R61, R33). 

Date: March 7, 2022. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6705 

Rockledge Drive, Bethesda, MD 20817 

(Virtual Meeting). 

Contact Person: Manoj Kumar 

Valiyaveettil, Ph.D., Scientific Review 

Officer, Office of Scientific Review/DERA, 

National Heart, Lung, and Blood Institute, 

National Institutes of Health, 6705 Rockledge 

Drive, Room 208–R, Bethesda, MD 20817, 

(301) 402–1616, manoj.valiyaveettil@nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Hemophilia A Analytical Cohort Research 

Program (UG3/UH3). 

Date: March 22, 2022. 

Time: 11:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6705 

Rockledge Drive, Bethesda, MD 20817, 

(Virtual Meeting). 

Contact Person: Manoj Kumar 

Valiyaveettil, Ph.D., Scientific Review 

Officer, Office of Scientific Review/DERA, 

National Heart, Lung, and Blood Institute, 

National Institutes of Health, 6705 Rockledge 

Drive, Room 208–R, Bethesda, MD 20817, 

(301) 402–1616, manoj.valiyaveettil@nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Limited Competition: Small Grant Program 

for NHLBI K01/K08/K23 Recipients (R03— 

Clinical Trial Optional). 

Date: March 23, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6705 

Rockledge Drive, Bethesda, MD 20817 

(Virtual Meeting). 

Contact Person: Kazuyo Kegan, AB, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Room 208–S, 

Bethesda, MD 20817, (301) 435–0270, 

kazuyo.kegan@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: January 19, 2022. 

David W Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–01367 Filed 1–24–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Nursing Research; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Nursing Research Special Emphasis Panel; 

Modular Budget Research Project Grant for 

NIH Nurse Scientist Scholars. 

Date: February 10, 2022. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Nursing 

Research, 6701 Democracy Blvd., Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Ming Yan, MD, Ph.D., 

Scientific Review Officer, Immunology 

(IMM), DPPS, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, RM 4205, Bethesda, MD 20892, 

yanming@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Nursing Research Initial Review Group. 

Date: February 24, 2022. 

Time: 9:00 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 16 / Tuesday, January 25, 2022 / Notices 3829 

Place: National Institute of Nursing 

Research, 6701 Democracy Blvd., Bethesda, 

MD 22150 (Virtual Meeting). 

Contact Person: Weiqun Li, MD, Scientific 

Review Officer, National Institute of Nursing 

Research, National Institutes of Health, 6701 

Democracy Blvd., Ste. 710, Bethesda, MD 

20892, (301) 594–5966, wli@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.361, Nursing Research, 

National Institutes of Health, HHS) 

Dated: January 19, 2022. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–01366 Filed 1–24–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review Group; 

Social Sciences and Population Studies B 

Study Section. 

Date: February 17–18, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Kate Fothergill, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3142, 

Bethesda, MD 20892, 301–435–2309, 

fothergillke@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Training in 

Veterinary and Comparative Medicine. 

Date: February 17, 2022. 

Time: 2:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ronit I. Yarden, Ph.D., 

MHSA, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 904B, 

Bethesda, MD 20892, (202) 552–9939, 

yardenri@csr.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Health Promotion in Communities Study 

Section. 

Date: February 22–23, 2022. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Helena Eryam Dagadu, 

MPH, Ph.D., Scientific Review Officer, Center 

for Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room 3137, 

Bethesda, MD 20892, 301–435–1266, 

dagaduhe@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA–RM– 

21–027: The Human BioMolecular Atlas 

Program (HuBMAP) Demonstration Project 

(U01). 

Date: February 22, 2022. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Allen Richon, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6184, 

MSC 7892, Bethesda, MD 20892, 301–379– 

9351, allen.richon@nih.hhs.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Cell Biology, Developmental 

Biology, and Bioengineering. 

Date: February 23–24, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Mufeng Li, Ph.D., 

Scientific Review Officer, The Center for 

Scientific Review, The National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, 301–435–5653, limuf@nih.gov. 

Name of Committee: Cardiovascular and 

Respiratory Sciences Integrated Review 

Group; Respiratory Integrative Biology and 

Translational Research Study Section. 

Date: February 24–25, 2022. 

Time: 9:00 a.m. to 7:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Bradley Nuss, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4142, 

MSC 7814, Bethesda, MD 20892, 301–451– 

8754, nussb@csr.nih.gov. 

Name of Committee: Musculoskeletal, Oral 

and Skin Sciences Integrated Review Group; 

Skeletal Muscle and Exercise Physiology 

Study Section. 

Date: February 24–25, 2022. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Richard Ingraham, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4116, 

MSC 7814, Bethesda, MD 20892, (301) 496– 

8551, ingrahamrh@mail.nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group; 

Genomics, Computational Biology and 

Technology Study Section. 

Date: February 24–25, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Methode Bacanamwo, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2200, 

Bethesda, MD 20892, 301–827–7088, 

methode.bacanamwo@nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group; 

Social Psychology, Personality and 

Interpersonal Processes Study Section. 

Date: February 24–25, 2022. 

Time: 9:30 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Janetta Lun, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room 1007E, 

Bethesda, MD 20892, (301) 435–5877, 

janetta.lun@nih.gov. 

Name of Committee: Infectious Diseases 

and Immunology B Integrated Review Group; 

Transplantation, Tolerance, and Tumor 

Immunology Study Section. 

Date: February 24–25, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Audrey O. Lau, MPH, 

Ph.D., Chief Center for Scientific Review, 

6701 Rockledge Drive, Bethesda, MD 20892, 

(301) 594–4088, audrey.lau@nih.gov. 

Name of Committee: Oncology 1—Basic 

Translational Integrated Review Group; 

Cancer Etiology Study Section. 

Date: March 1–2, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sarita Kandula Sastry, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 


khammond on DSKJM1Z7X2PROD with NOTICES